Analysts Expect Phibro Animal Health Corporation (PAHC) to Announce $0.39 EPS

Wall Street analysts forecast that Phibro Animal Health Corporation (NASDAQ:PAHC) will post earnings of $0.39 per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Phibro Animal Health’s earnings. The highest EPS estimate is $0.40 and the lowest is $0.36. Phibro Animal Health also posted earnings per share of $0.39 in the same quarter last year. The business is expected to report its next quarterly earnings report on Monday, February 5th.

On average, analysts expect that Phibro Animal Health will report full year earnings of $1.57 per share for the current financial year, with EPS estimates ranging from $1.55 to $1.58. For the next financial year, analysts expect that the company will report earnings of $1.68 per share, with EPS estimates ranging from $1.65 to $1.73. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research analysts that follow Phibro Animal Health.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.01. The business had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The firm’s revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.36 EPS.

Several equities research analysts have recently issued reports on PAHC shares. Zacks Investment Research upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price target for the company in a report on Tuesday, October 31st. Piper Jaffray Companies set a $41.00 price target on Phibro Animal Health and gave the company a “buy” rating in a report on Friday, October 6th. BidaskClub lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Finally, Credit Suisse Group lifted their price target on Phibro Animal Health from $36.00 to $37.00 and gave the company an “outperform” rating in a report on Thursday, August 31st. Three research analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $38.25.

Shares of Phibro Animal Health (NASDAQ:PAHC) traded down $0.95 during trading on Friday, hitting $33.75. The stock had a trading volume of 96,879 shares, compared to its average volume of 89,496. The firm has a market cap of $1,394.35, a price-to-earnings ratio of 22.68, a price-to-earnings-growth ratio of 4.07 and a beta of 1.28. The company has a current ratio of 3.26, a quick ratio of 1.85 and a debt-to-equity ratio of 1.91. Phibro Animal Health has a fifty-two week low of $26.10 and a fifty-two week high of $40.25.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Wednesday, December 6th will be paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date of this dividend is Tuesday, December 5th. Phibro Animal Health’s payout ratio is 23.53%.

In related news, CFO Richard G. Johnson sold 55,529 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $36.30, for a total value of $2,015,702.70. Following the transaction, the chief financial officer now directly owns 15,900 shares of the company’s stock, valued at approximately $577,170. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Richard G. Johnson sold 29,807 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $35.66, for a total value of $1,062,917.62. Following the completion of the transaction, the chief financial officer now directly owns 4,240 shares in the company, valued at $151,198.40. The disclosure for this sale can be found here. Insiders sold a total of 279,791 shares of company stock worth $10,118,331 over the last three months. 51.88% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Morgan Stanley increased its position in Phibro Animal Health by 1.7% in the 1st quarter. Morgan Stanley now owns 172,773 shares of the company’s stock worth $4,855,000 after buying an additional 2,868 shares during the period. Janus Henderson Group PLC bought a new position in Phibro Animal Health in the 2nd quarter worth approximately $6,353,000. Prudential Financial Inc. increased its position in Phibro Animal Health by 59.0% in the 3rd quarter. Prudential Financial Inc. now owns 141,760 shares of the company’s stock worth $5,253,000 after buying an additional 52,590 shares during the period. Dimensional Fund Advisors LP increased its position in Phibro Animal Health by 5.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 416,001 shares of the company’s stock worth $15,413,000 after buying an additional 19,994 shares during the period. Finally, Sawgrass Asset Management LLC bought a new position in Phibro Animal Health in the 2nd quarter worth approximately $410,000. 48.42% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Analysts Expect Phibro Animal Health Corporation (PAHC) to Announce $0.39 EPS” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/12/02/analysts-expect-phibro-animal-health-corporation-pahc-to-announce-0-39-eps.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Get a free copy of the Zacks research report on Phibro Animal Health (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply